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ABSTRACT 
Objectives: Analysis of national surveillance data and a sero- 
epidemiologic investigation were conducted to elucidate the 
causes and epidemiologic characteristics of a measles out- 
break in Taoyuan, Taiwan, 1994. 
Methods: Measles cases were identified through a national sur- 
veillance system. Reported cases and their physician or school 
nurses were interviewed to trace additional suspect cases and 
were sampled for serologic diagnosis, Measles-specific IgG 
and IgM were assayed. A confirmed case was defined as being 
positive for measles IgM test but not having received measles 
vaccination within the previous 3 months. 
Results: The outbreak began in Taoyuan City in December 1993 
and continued to spread in primary schools and kindergartens, 
but caused only sporadic cases in neighboring towns. Among 
42 confirmed cases, 15 (38%) were primary school children and 
16 (38%) were kindergarten children. Among 24 confirmed cases 
with a vaccination record, 7 had one dose of vaccination, 4 had 
two doses of vaccination, and 13 (54%) were unvaccinated. The 
overall measles susceptible proportion at a kindergarten before 
the outbreak was 8.1% (17/209) and the overall measles cumu- 
lative incidence among susceptibles was 0.65 (1 l/l 7). 
Conc/usions: A measles vaccination coverage of 82% with the 
first dose at 9 months of age and 63% with the second dose 
(measles, mumps, and rubella) at 15 months was inadequate 
to block measles virus circulation in Taoyuan City in 1994. The 
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city center, with a growing population, represents a high risk 
as an epicenter for measles outbreaks. Measles outbreaks may 
occur in a school population with 92% herd immunity. 
Key Words: herd immunifL: measles outbreak, 
seroepidemiology, vaccine efficacy 
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Measles is an acute and highly contagious viral disease. It 
remains a major killer of infants in developing countries 
with low vaccination coverage, and continues to cause out- 
breaks in countries with over 90% vaccination coverage, 
despite the fact that an effective live-attenuated measles 
vaccine has been licensed since the 1960s.lm3 Epidemio- 
logic and theoretic studies suggest that measles can be 
eradicated for the following reasons: (1) humans are its 
only natural host, (2) persistent infection is rare and can- 
not serve as source of transmission, and (3) effective vac- 
cines are available, and (4) the virus has a high degree of 
antigenic stability l-’ Moreover, because measles vaccina- 
tion is highly cost-effective, the World Health Organization 
(WHO) has proposed establishing a goal of eradicating 
measles virus globally by the year 2005 to 2010.” 
Historically, measles infection in Taiwan has been 
widespread, with epidemics occurring every 2 years 
before the introduction of mass immunization in 1978. 
Since then, measles mortality rates had decreased signifi- 
cantly, but reports of measles cases continued with peri- 
odic large-scale, island-wide outbreaks in 1984-85 and 
1988-89. In an effort to adjust to the transitional nature 
of the epidemiologic characteristics of the measles infec- 
tion in Taiwan, researchers changed the recommended 
measles vaccination schedule several times during this 
period: one dose at 9 months of age established in 1978, 
two doses at 9 and 15 months of age beginning at 1984, 
returning to one dose at 12 months of age in January 
1988, and again to two doses in May 1988. Since 1991, 
measles, mumps, and rubella (MMR) vaccine has been 
introduced to replace the second dose of measles vaccine 
in 15-month-old children.5-6 In addition, a mass campaign 
64 
Measles Outbreak in Taoyuan County, Taiwan / Lee et al 65 
of MMR vaccination among primary and secondary school 
children was conducted in 1991-93. The coverage rate 
achieved in the target population during the campaign 
was approximately 90%.’ Following a l-year-period of near 
zero incidence, a measles outbreak erupted in Taoyuan 
County in the spring of 1994. To investigate and elucidate 
the epidemiologic characteristics of measles transmission 
against a background of a moderately high level of measles 
vaccine coverage, the authors analyzed surveillance data 
and conducted an active hospital, community, and school 
investigation as well as a seroepidemiologic study in a 
kindergarten where measles was erupting. 
MATERIALS AND METHODS 
Background 
Taoyuan County consists of 13 cities or towns and its 
administrative and economic center, Taoyuan City is only 
30 km from the capital, Taipei City. The population and 
population density in Taoyuan City in 1990 were 241,263 
persons (6932 persons/km2), which increased to 260,680 
persons (7490 persons/km2) in 1994.* Based on the 
health statistics of Taoyuan City, the vaccination coverage 
of measles vaccine at !&month-old and MMR vaccine at 
15-month-old in 1993 were 82% and 63%, respectively. 
Surveillance Data 
Measles is a reportable disease in Taiwan. Physicians rou- 
tinely report suspect cases (fever, rash, and one of cough, 
coryza, and conjunctivitis) to the appropriate County 
Health Department, which assumes the responsibility of 
collecting blood samples for case verification (serology 
done at National Institute of Preventive Medicine [NIPM]), 
as well as interviewing the physicians and contacts of the 
cases, to identify the source and the size of the outbreak. 
After 11 months without any reported measles cases, 
the Taoyuan County Health Bureau noted an apparent 
increase in the reported cases of measles at the beginning 
of 1994; however, their attempt to identity the geographic 
or demographic linkage between these reported cases 
was unsuccessful. On May 10, based on the preliminary 
reporting data, which identified the high risk group of the 
outbreak as kindergarten and primary school children, 
national health authorities at the Department of Health 
(DOH) alerted local physicians to report any further sus- 
pect cases and advised the Taoyuan County Health 
Bureau to accelerate the MMR campaign among primary 
school children who were not immunized as originally 
scheduled in 1993, owing to a shortage of MMR vaccine. 
Seroepidemiologic Investigation and Outbreak 
Control 
On May 18, the NIPM joined the local health authority in 
the efforts to interview the reported cases, local physi- 
cians, and school nurses and noted that the outbreak was 
spreading from a primary school to a kindergarten in 
Taoyuan City. Consequently, a seroepidemiologic investi- 
gation was initiated in the affected kindergarten. A self- 
administered questionnaire (including demographic, 
clinical, and vaccination information) was sent to parents 
of the kindergarten children, and serum samples were 
collected from the kindergarten children, with parents’ 
consent, before an emergency immunization with one 
dose of MMR on June 9,1994. Also in June, the Taoyuan 
County Health Bureau initiated a check of the vaccination 
records of all kindergarten children in Taoyuan County 
and subsequently immunized, with one dose of MMR vac- 
cine, those children who had never received MMR 
vaccination. 
Measles Antibody Tests 
Measles IgG and IgM were assayed in all serum samples, 
using a commercial enzyme-linked immunosorbent assay 
(ELISA) kit (Biowhittaker Inc., Maryland, USA). Measles 
IgG-negative specimens were retested for measles IgG by 
means of another commercial ELISA kit (Enzygnost 
Measles, Behring, Marburg, Germany), which offered 
greater sensitivity than the former kit.’ A confirmed case 
of measles infection was defined as one having tested 
positive for measles IgM in an individual who received no 
measles vaccination within the previous 3 months.‘O 
Vaccine Effectiveness and Vaccine Failure Rate 
The vaccination status of all reported cases and kinder- 
garten children was determined according to their vacci- 
nation record. Kindergarten children who did not 
participate in the serosurvey were excluded from analysis. 
Each immunized child with a positive assay for measles 
IgM or a negative assay for measles IgG was classified as a 
case of vaccine failure. Vaccine effectiveness was estimated 
according to the method of Orenstein et al.‘l 
Statistical Analysis 
The statistical association between two nominal or ordi- 
nal variables was tested by the chi-square, Fisher’s exact 
or Mantel-Haenszel &i-square test for trend. The 95% con- 
fidence intervals (CI) of vaccine effectiveness also were 
calculated.12 All the statistical analyses were conducted by 
Epi Info, Version 6,‘s 
RESULTS 
Descriptive Epidemiology 
Forty-two laboratory-confirmed cases and seven clinically 
suspect cases without blood specimens were identified. 
Among 42 confirmed cases, 22 (52%) were identified 
through physician reporting and 20 (48%) were found 
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Figure 1. Epicurve of measles outbreak in Taoyuan County, Taiwan, 
September 1993 to August 1994, categorized by the methods of sur- 
veillance (top) and by age group (bottom). Two of 42 confirmed cases 
were lost to follow-up. 
through active investigation, such that the proportion of 
cases found through physician reporting was 32% (S/25) 
between March and May, which increased to 87.5% (7/S) 
in June Cp < 0.05, Fisher’s exact test) Figure 1, top>. The 
age distribution of the 42 confirmed cases was as fol- 
lows: 15 (38%) primary school children (7-12 y), 16 (38%) 
kindergarten children (4-6 y), 7 (17%) preschool chil- 
dren (l-3 y), and 3 (7%) infants (< 1 y) (Table 1). Of the 
24 confirmed cases who had a vaccination record, 7 
(29%) had received one dose of vaccination, 4 (17%) had 
Table 1. Age Distribution and Vaccination History of Measles 
Cases in Taoyuan, Taiwan, December 1993-June 1994 
Characteristics Laboratory-Confirmed Clinically Suspect 
Cases (n=42) Cases (n=7) 
n (%) n (%) 
Age (Y) 
58 months 1 (2) 1 (14) 
9-11 months 2 (51 2 (29) 
1-3 7 (17) 0 
4-6 16 (38) 0 
7-l 2 15 (36) 3 (43) 
213 1 (2) 1 (14) 
Doses and age at vaccination 
One dose 7 (29) 1 (20) 
<I 2 months 5 0 
212 months 1 
Two doses 4 (1; 0 
Unvaccinated 13 (54) 4 (80) 
No record 18 2 
received two doses of vaccination, and 13 (54%) were 
unvaccinated (see Table 1). The outbreak erupted from 
Taoyuan City in December 1993 and continued to spread 
in primary schools and kindergartens (Figure 1, bottom) 
but caused only sporadic cases in neighboring towns 
(data not shown). Since July 1994, Taoyuan County Health 
Bureau has not observed any confirmed cases of measles. 
Seroepidemiologic Investigation 
Among 312 kindergarten children, 209 (67%) children 
participated in the serosurvey. Those children who par- 
ticipated in the serosurvey were similar to total children 
with respect to age (61%, 69%, and 68%, P = 0.56, chi- 
square test, Table 2) and vaccination history (83% vs 79%, 
P = 0.27, chi-square test, Table 3). The overall measles 
IgM seropositive proportion was 5.3% (1 l/209) and var- 
ied from 0% in grade 2 to 5.7% in grade 1 and 11.8% in 
grade 3 (P < 0.05, Fisher’s exact test). The overall measles 
IgG seronegative proportion was 2.9% (G/209) and var- 
ied from 0% in grade 3 to 8.6% in grade 1 and 3.1% in 
grade 2 (P < 0.05, Fisher’s exact test). The susceptible 
proportion and cumulative incidence among suscepti- 
bles were 14.3% and 0.4 in grade 1,3.1% and 0 in grade 
2, and 11.8% and 1.0 in grade 3, respectively (P < 0.05, 
Fisher’s exact test) (see Table 2). 
Among 312 kindergarten children, 249 (79%) chil- 
dren had received measles vaccination, 14 (5%) children 
were unvaccinated, and 51 (16%) children had no vacci- 
nation record. The attack rates significantly decreased 
from 28.6% in unvaccinated children to 6.0% in one-dose 
vaccinees, 3.3% in two-dose vaccinees, and 0% in three- 
dose vaccinees (P = 0.02, &i-square test for trend) (see 
Table 3). The overall vaccine effectiveness was 86% (95% 
CI = 44-96) and increased from 79% (95% CI = 6-95) for 
one dose to 88% (95% CI = 41-98) for two doses and 
100% for three doses (see Table 3). The overall vaccine 
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Table 2. Susceptible Proportion and Cumulative Incidence by Grade during Measles Outbreak 
in a Kindergarten in Taoyuan, Taiwan, May-June 1994 
Grade Age (u Children Serum Measles Susceptible* Cumulative Incidence? 
IgM (+) I@ (-) 
n n (%) n (%) n (%) n (%) 
1 3-4 57 35 (61) 2 (5.7) 3 (8.6) 5 (14.3) 0.40 
2 4-5 143 98 (69) OX 3 (3.1) 3 (3.1) OZ 
3 5-6 112 76 (68) g(ll.8) 0* 9 (11.8) 1 .oo 
Total 3-6 312 209 (67) 11 (5.3) 6 (2.9) 17 (8.1) 0.65 
*Includes measles IgG-negative and IgM-positive children: ‘number IgM+/number susceptible: *P < 0.05, Fisher’s exact test. 
failure rate was 6.4% (95% CI = 3.2-l 1.1) and decreased 
from 10.4% (95% CI = 4.3-20.3) for one dose to 4.4% 
(95% CI = 1.2-11.0) for two doses and 0% for three doses 
(P = 0.06, chi-square test for trend) (see Table 3). Ten 
children receiving one dose of measles vaccine before 
12 months of age had the lowest vaccine effectiveness 
(30%, 95% CI = O-87) and the highest vaccine failure 
rates (20%, 95% CI = 2.5-55.6). However, attack rates (P 
= 0.12, &i-square test for trend), vaccine effectiveness, 
and vaccine failure rates (P = 0.48, chi-square test for 
trend) were not associated with age at vaccination, prob- 
ably because of small sample size (see Table 3). 
DISCUSSION 
The high proportion (54%) of confirmed measles cases 
in the surveillance data that were unvaccinated, in con- 
junction with the well-monitored vaccine coverage of 
approximately 79% (32% with 1 dose and 47% with 22 
doses) among the kindergarten children, are highly sug- 
gestive that the cause of this outbreak may be attributed 
to lack of vaccination. In addition, based on the local 
health statistics, the measles vaccine coverage of first dose 
at 9 months of age and MMR vaccine at 15 months in 
1993 were 82% and 63%, respectively Consequently the 
Department of Health in Taiwan has recommended that 
all kindergarten and primary school children should 
receive two doses of measles-containing vaccine and has 
implemented this policy by checking vaccination records 
and undertaking “catch-up” immunization, since June 1994. 
The overall measles susceptible proportion before 
the outbreak at the kindergarten in this study was 8.1% 
but varied from 3.1% in grade 2 to 14.3% in grade 1. This 
showed that a measles outbreak can erupt in a school 
population characterized by 92% herd immunity. 
Gustafson et al also found that a measles outbreak 
occurred in a secondary school with 95% herd immunity 
as measured by a measles IgG ELBA.‘* Mathematic mod- 
elling research has predicted that measles is eradicable if 
vaccine-induced immunity lasts lifelong and herd immu- 
nity homogeneously reaches 90 to 95%.‘j However, in 
reality neither vaccine uptake nor contact patterns are 
randomly distributed, which has an important implica- 
tion for the design of immunization programs, which 
must recognize the distribution of susceptibles and 
reduce their concentration.16-18 In addition, other con- 
tributing factors for a measles outbreak in a highly vac- 
cinated population are primary and secondary vaccine 
failures.‘9-21 
Primary vaccine failure is strongly a.ssociated with 
the age at vaccination. Among children over 15 months 
of age, measles vaccines are highly efficacious with sero- 
conversion over 95% in a hospital-based short-term eval- 
uation.lm3 However, the efficacy and seroresponse of 
measles vaccine decreased to 85 to 95% in the setting of 
Table 3. Measles Vaccine Effectiveness (VE) and Vaccine Failure Rates (VFR) Among Kindergarten Children 
in Taoyuan County, Taiwan, June 1994 
Vaccination Measles Attack VE+ Measles VFR’ 
History Children Serum WI (+) Rate* 
(952 Cly 
/gG C-1 % 
(Doses &Age) n (%) n (%) n % n (95% Cl)” 
Vaccinated 247 (79) 173 (83) 7 4.0 86(44-96) 4 6.4 (3.2-11.1) 
Onedose 99 (32) 67 (32) 4 6.0 79 ( 6-95) 3 10.4 (4.3-20.3) 
<I 2 months 12 10 2 20.0 30(0-87) 0 20.0 (2.5-55.6) 
12-14months 33 25 2 8.0 72(0-95) 0 8.0 (1.0-26.0) 
>14months 14 10 0 0 100 1 10.0(0.3-44.5) 
Unknown 40 22 0 0 100 2 9.1 (1 .l-29.2) 
Two doses 126 (40) 90 (43) 3 3.3 88(41-98) 1 4.4 (1.2-l 1 .O) 
Threedoses 22 (7) 16 (8) 0 0 100 0 0 
Unvaccinated 14 (5) 7 (3) 2 28.6 Reference 0 
No record 51 (16) 29 (14) 2 6.9 2 
Total 312 209 11 5.3 6 
*Attack rate = No. of Measles IgM(+) / No. of Serum; +VE= ([ARU-ARV]/ARU), where AR&attack rate of unvaccinated, ARV=attack rate of 
vaccinees; WFR= [No. of IgM(+) plus No. of IgG(-)] /No. of Vaccinees; d95%Ci=95% confidence interval. 
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community health stations and clinics, because of the 
problems of cold chain, work load, and injection tech- 
nique. 1-3~22,23 Although the immunity of current live-atten- 
uated measles vaccine is believed to be durable,‘a19 
additional evidence has shown that secondary vaccine 
failure is not rare, especially in a highly vaccinated pop- 
ulation with low possibility of natural booster from wild 
virus.24-29 Two longitudinal studies detected 5% (9/175) 
and 1.2% (4/333) secondary vaccine failure rates during 
a follow-up of 10 years in Canada and 12 years in China, 
respectively.24,25 In addition, Chen et al in the United 
States and Hirose et al in Japan also serologically docu- 
mented seven and five clinical cases of secondary vaccine 
failure, respectively- x*’ Moreover, two other studies also 
proposed the existence of secondary vaccine failure 
based on the observation of an IgM response in only 
77.4% and 84.3% of vaccinated measles cases, respec- 
tively. 28,29 Although secondary vaccine failure may cause 
mild symptoms and not appear to be a major impedi- 
ment to measles control at the moment, it needs to be 
continuously monitored until the success of global 
measles eradication.4,29,30 
This study cannot differentiate primary from sec- 
ondary vaccine failure because of the shortage of paired 
sera. The overall vaccine failure rate in this study was 
6.4%, which varied from 20% for one dose under 12 
months of age to 8% for one dose at 12 to 14 months, 
and 4.4% for two doses of measles vaccination, figures 
that are similar to those reported in a hospital-based sero- 
conversion study among infants and young children in 
1988 in Taipei31 The strategy of two doses of measles 
vaccination at 9 and 15 months, implemented since 1988, 
should have reduced the susceptibles among children 
under 6 years of age, but high vaccine failure rate (20%) 
for the first dose at 9 months of age and low coverage 
(63%) for the second dose may have been responsible 
for the increased overall risk of measles infection among 
this birth cohort. The health authority in Taiwan should 
consider changing the recommended age of the first dose 
from 9 months to 12 months when measles activity is so 
low that infants have a low probability of exposure to 
measles cases. 
The policy of a single booster of measles vaccine (or 
MMR) among kindergarten or school children, to improve 
both individual protection and herd immunity by reduc- 
ing the primary and secondary vaccine failure, is widely 
applied in many countries. 3,4,32,33 The optimal ages and 
strategy (e.g., “catch-up” in unimmunized individuals or 
universal immunization) should be determined by vac- 
cine coverage and seroepidemiologic data, particularly 
considering the waning of vaccine-induced immunity and 
long-term effect of revaccination.34-38 In addition, the 
requirement of mandatory measles immunization should 
be extended to nurseries, to further reduce the risk of a 
measles outbreak. 
The city center, with a high population density often 
acts as the epicenter of respiratory infectious diseases, 
such as measles and influenza.2~6~39~40 During an island- 
wide measles epidemic in 1988-89 in Taiwan, Lee et al 
found that the measles outbreak started in the capital 
(Taipei City), persisted for 15 months, and gradually 
spread to neighboring counties.6 Therefore, measles sur- 
veillance must strengthen its timeliness in urban areas, to 
constrain the extent of any outbreak through the imple- 
mentation of timely control actions. 
The goal of measles elimination in Taiwan by 2000 
has been established.’ Although no confirmed case was 
detected in 1995-96, five sporadic confirmed cases 
occurred in 1997, and a small outbreak, with nine con- 
firmed cases, erupted in 1998.*r Based on the findings of 
this study, the future direction for measles elimination in 
Taiwan may focus on (1) increasing the two-dose cover- 
age of measles vaccination to over 90% in preschool chil- 
dren; (2) sustaining the two-dose coverage to over 95% 
in nursery, kindergarten, and primary schools, by check- 
ing immunization records and immunizing unvaccinated 
individuals; (3) strengthening the efficiency of the sur- 
veillance system; and (4) combining seroepidemiologic 
data and mathematic modelling to design the optimal 
immunization policy. 
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